American Chemical Society--235th National Meeting. Part 2
Hookes, L.; Lakeram, M.
IDrugs the investigational drugs journal 11(6): 391-393
2008
ISSN/ISBN: 1369-7056 PMID: 18509774 Document Number: 627001
Document emailed within 1 workday
Related Documents
Chan, D.; Mackonochie, M. 2005: American Chemical Society--229th National Meeting. Oncology IDrugs: the investigational drugs journal 8(4): 280-282Rotella, D.P. 2005: American Chemical Society - 229th National Meeting: carbohydrate vaccines IDrugs: the investigational drugs journal 8(5): 387-389
Mazucco, R.A.; Ognjenovic, M. 2003: American Chemical Society--225th national meeting. 23-27 March 2003, New Orleans, LA, USA IDrugs: the investigational drugs journal 6(5): 403-416
Brown, H. 2001: American Chemical Society--222nd national meeting. Cannabinoids: a tale of use and abuse IDrugs: the investigational drugs journal 4(10): 1096-1099
Turner, B.; Bright, J. 2007: American Chemical Society--233rd National Meeting. 25-29 March 2007, Chicago, IL, USA IDrugs: the investigational drugs journal 10(5): 297-299
Mackonochie, M.; Chan, D. 2005: American Chemical Society--229th National Meeting. Oral and poster presentations IDrugs: the investigational drugs journal 8(4): 285-287
Rotella, D.P. 2005: American Chemical Society - 229th National Meeting: bench to pilot plant IDrugs: the investigational drugs journal 8(5): 390-391
Ognjenovic, M.; Paterson, D. 2004: American Chemical Society--228th National Meeting. Metabolism. 22-26 August 2004, Philadelphia, PA, USA IDrugs: the investigational drugs journal 7(10): 898-900
Dalziel, C.; Veryard, C. 2007: American Chemical Society--234th National Meeting. Therapeutics for neurological indications. 19-23 August 2007, Boston, MA, USA IDrugs: the investigational drugs journal 10(10): 676-677
Rotella, D.P. 2005: American Chemical Society--230th National Meeting. Proteins, peptides, amino acids and enzyme inhibitors IDrugs: the investigational drugs journal 8(11): 878-879
Rotella, D.P. 2006: American Chemical Society--231st National Meeting. Virtual screening using structure-based and ligand-based methods for lead identification IDrugs: the investigational drugs journal 9(5): 331-333
Rotella, D.P. 2004: American Chemical Society--227th annual meeting. Diabetes. 28 March - 1 April 2004, Anaheim, CA, USA IDrugs: the investigational drugs journal 7(5): 428-429
Walker, K.; Kibble, A.; Shumoogam, J. 2007: American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1 IDrugs: the investigational drugs journal 10(8): 513-516
Yu, E.Y. 2011: Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting Clinical Advances in Hematology and Oncology: H&o 9(8 Suppl. 21): 1-24
1932: Sections F and G (Botanical and Zoological Sciences). **american Society of Naturalists. **ecological Society of America. **american Microscopical Society. Genetics Sections, American Society of Zoologists and Botanical Society of America. Daggerphi Sigma Biological Research Society Science 75(1936): 161-162
1932: Sections F and G (Botanical and Zoological Sciences). **american Society of Naturalists. **ecological Society of America. **american Microscopical Society. Genetics Sections, American Society of Zoologists and Botanical Society of America. Daggerphi Sigma Biological Research Society Science 75(1936): 161-162
Aharony, L. 2004: American Geriatrics Society, Annual Scientific Meeting, Baltimore May 2003 Harefuah 143(2): 149-151
McGowran, M. 2001: American Society of Gene Therapy - Fourth Annual Meeting. 30 May-3 June 2001, Seattle, WA, USA IDrugs: the investigational drugs journal 4(8): 896-900
1983: Society for Hospital Planning. AHA Fifth Annual Meeting. Part I Health Care Strategic Management 1(1): 29-34
2018: 1st Meeting in Translational Pharmacology, 38th SEF national meeting/9th SEFF meeting 19-20 June 2018, Spain Basic and Clinical Pharmacology and Toxicology 123 Suppl. 2: 3-96